Literature DB >> 18553115

Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot study.

Elif Suyani1, Mehmet Akif Ozturk, Serpil Muge Deger, Mehmet D Demirag, Berna Goker, Seminur Haznedaroglu.   

Abstract

We investigated the association between familial Mediterranean fever (FMF) and osteoporosis (OP) in adult patients. Thirty-five attack-free FMF patients (28 females, 7 males; mean age 36.9 +/- 5.7 years) were individually matched to control subjects on the basis of age (within 2 years) and sex. All patients were taking regular colchicine. Subjects having any condition that can cause decreased bone mineral density (BMD) were excluded from the study. BMD was measured at the spine and femur by dual X-ray absorptiometry (DXA). Data was given as the median (IQR). T scores of the spine were -0.700 (-1.097 to -0.262) and -0.450 (-0.830 to 0.112) in FMF patients and healthy controls, respectively (p > 0.05). T scores of the femur neck were -0.900 (-1.480 to -0.570) and -0.430 (-1.472 to 0.247) in FMF patients and healthy controls, respectively (p > 0.05). Total femur T scores were significantly lower in FMF patients than healthy controls (-0.780 [-1.222 to -0.085] vs. -0.100 [-0.765 to 0.537], respectively, p = 0.021). Total femur T scores were significantly decreased in adult patients with FMF. Ongoing subclinical inflammation may be associated with decreased bone mineral content in those patients.

Entities:  

Mesh:

Year:  2008        PMID: 18553115     DOI: 10.1007/s10067-008-0930-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  Acute phase response and evolution of familial Mediterranean fever.

Authors:  M Tunca; G Kirkali; M Soytürk; S Akar; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

Review 2.  Osteoporosis in premenopause. When are screening and treatment prudent?

Authors:  Chris T Derk
Journal:  Postgrad Med       Date:  2006 Jun-Jul       Impact factor: 3.840

3.  Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever.

Authors:  S Haznedaroglu; M A Oztürk; B Sancak; B Goker; A M Onat; N Bukan; I Ertenli; S Kiraz; M Calguneri
Journal:  Clin Exp Rheumatol       Date:  2005 Jul-Aug       Impact factor: 4.473

4.  Interferon-gamma levels in familial Mediterranean fever.

Authors:  Seyfettin Köklü; Mehmet Akif Oztürk; Mustafa Balci; Osman Yüksel; Ihsan Ertenli; Sedat Kiraz
Journal:  Joint Bone Spine       Date:  2005-01       Impact factor: 4.929

Review 5.  Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.

Authors:  E Romas; M T Gillespie; T J Martin
Journal:  Bone       Date:  2002-02       Impact factor: 4.398

Review 6.  Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

Authors:  Benjamin M P Tang; Guy D Eslick; Caryl Nowson; Caroline Smith; Alan Bensoussan
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

Review 7.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

8.  Osteoporosis, inflammation and ageing.

Authors:  Lia Ginaldi; Maria Cristina Di Benedetto; Massimo De Martinis
Journal:  Immun Ageing       Date:  2005-11-04       Impact factor: 6.400

9.  Nonpharmacological prevention of osteoporotic fractures.

Authors:  Cathy R Kessenich
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 10.  Role of RANKL inhibition in osteoporosis.

Authors:  Michael McClung
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  8 in total

1.  Bone mineral density in familial Mediterranean fever.

Authors:  Neslihan Berkdemir Siverekli; Ozlem Sahin; Soner Senel; Emrullah Hayta; Ece Kaptanoglu; Hasan Elden
Journal:  Rheumatol Int       Date:  2011-07-08       Impact factor: 2.631

2.  Low plasma vitamin D levels in patients with familial Mediterranean fever.

Authors:  Sükran Erten; Alpaslan Altunoğlu; Gülay Güleç Ceylan; Yüksel Maraş; Cemile Koca; Aydan Yüksel
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

Review 3.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  Cephalometric evaluation of children with familial Mediterranean fever.

Authors:  Ahmet Yalcin Gungor; Vefik Arica; Ozge Gungor; Murat Tutanc
Journal:  Angle Orthod       Date:  2011-11-29       Impact factor: 2.079

5.  Serum bone markers levels and bone mineral density in familial mediterranean Fever.

Authors:  Teoman Aydın; Ozgur Taspınar; Yildiz Akbal; Celaleddin Peru; Mustafa Guler; Omer Uysal; M Cengiz Yakıcıer
Journal:  J Phys Ther Sci       Date:  2014-09-17

6.  Bone Mineral Density in Egyptian Children with Familial Mediterranean Fever.

Authors:  Samia Salah; Sahar A El-Masry; Hala Fathy Sheba; Rokia A El-Banna; Walaa Saad
Journal:  Iran J Med Sci       Date:  2016-01

7.  Vitamin D levels in children with familial Mediterranean fever.

Authors:  Hatice Onur; Hale Aral; Vefik Arica; Gamze Atalay Bercem; Ozgur Kasapcopur
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-27       Impact factor: 3.054

8.  Osteoporosis in Systemic Autoinflammatory Diseases: A Case-Control Study.

Authors:  Sara Bindoli; Giulio Franceschet; Paola Galozzi; Martina Zaninotto; Valentina Camozzi; Paolo Sfriso
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.